Combinations comprising DMXAA for the treatment of cancer

Details for Australian Patent Application No. 2006283371 (hide)

Owner Antisoma Plc

Inventors Kelland, Lloyd; Rowlinson-Busza, Gail; Green, Colin

Agent Shelston IP

Pub. Number AU-A-2006283371

PCT Pub. Number WO2007/023302

Priority 0517386.9 26.08.05 GB; 0604114.9 02.03.06 GB

Filing date 25 August 2006

Wipo publication date 1 March 2007

International Classifications

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

13 March 2008 PCT application entered the National Phase

  PCT publication WO2007/023302 Priority application(s): WO2007/023302

15 April 2010 Assignment before Grant

  Antisoma Plc The application has been assigned to Antisoma Research Limited

22 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006283376-Combinations comprising DMXAA for the treatment of cancer

2006283366-Method